Mirikizumab - Subcutaneous (SC) clinical trials

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

This study is looking at new treatments for Crohn's disease. Researchers are testing a new drug, LY4395089, with an existing drug, mirikizumab, to see if they work better together than mirikizumab alone. They want to find out if this combination is safe and effective for adults.